» Articles » PMID: 16868749

Functional and Molecular Alterations of the Glomerular Barrier in Long-term Diabetes in Mice

Overview
Journal Diabetologia
Specialty Endocrinology
Date 2006 Jul 27
PMID 16868749
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Aims/hypothesis: Despite the fact that diabetic nephropathy is an increasingly common disorder that may lead to uraemia, the underlying mechanisms are still poorly understood and there is no specific therapy. To clarify whether long-term diabetes alters glomerular size- or charge-selectivity or both, we studied non-obese diabetic mice for up to 40 weeks.

Materials And Methods: During the study period, spot urine was collected and blood pressure measured. At weeks 10 and 40, the right kidney was isolated and perfused at 8 degrees C to inhibit tubular function, allowing for analysis of glomerular selectivity with albumin and Ficoll clearance. The left kidney was removed for further investigation using electron microscopy and molecular biology. Real-time PCR with low-density arrays was done to evaluate renal cortex mRNA expression of proteoglycans and other components in the glomerular barrier. After 40 weeks of diabetes, kidneys showed morphological changes typical of diabetic complications.

Results: At 40 weeks, the fractional clearance for negatively charged albumin was three times higher in the diabetic animals (0.0160) than in controls (0.0051, p<0.001), while fractional clearance for neutral Ficoll 35.5 A with a Stokes Einstein radius similar to that of albumin was unaffected. In addition, protein and mRNA levels for versican and decorin were downregulated after 40 weeks of diabetes.

Conclusions/interpretation: We conclude that glomerular charge- but not size-selectivity was impaired in the diabetic animals with proteinuria. Also, glomerular components such as versican, decorin and fibromodulin were found to be downregulated after 40 weeks of diabetes.

Citing Articles

Early diabetic kidney disease: Focus on the glycocalyx.

Yu H, Song Y, Li X World J Diabetes. 2023; 14(5):460-480.

PMID: 37273258 PMC: 10236994. DOI: 10.4239/wjd.v14.i5.460.


Endothelial glycocalyx in retina, hyperglycemia, and diabetic retinopathy.

Kaur G, Harris N Am J Physiol Cell Physiol. 2023; 324(5):C1061-C1077.

PMID: 36939202 PMC: 10125029. DOI: 10.1152/ajpcell.00188.2022.


Mineralocorticoid receptor antagonism in diabetes reduces albuminuria by preserving the glomerular endothelial glycocalyx.

Crompton M, Ferguson J, D Ramnath R, L Onions K, Ogier A, Gamez M JCI Insight. 2023; 8(5).

PMID: 36749631 PMC: 10077489. DOI: 10.1172/jci.insight.154164.


New insights into proteinuria/albuminuria.

Comper W, Vuchkova J, McCarthy K Front Physiol. 2022; 13:991756.

PMID: 36225307 PMC: 9548894. DOI: 10.3389/fphys.2022.991756.


Commentary: The Glomerular Endothelium Restricts Albumin Filtration.

Comper W Front Med (Lausanne). 2022; 9:861566.

PMID: 35295597 PMC: 8919079. DOI: 10.3389/fmed.2022.861566.


References
1.
Ciarimboli G, Hjalmarsson C, Bokenkamp A, Schurek H, Haraldsson B . Dynamic alterations of glomerular charge density in fixed rat kidneys suggest involvement of endothelial cell coat. Am J Physiol Renal Physiol. 2003; 285(4):F722-30. DOI: 10.1152/ajprenal.00227.2001. View

2.
Border W, Noble N, Yamamoto T, Harper J, Yamaguchi Y, Pierschbacher M . Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature. 1992; 360(6402):361-4. DOI: 10.1038/360361a0. View

3.
Vernier R, Steffes M, MAUER S . Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus. Kidney Int. 1992; 41(4):1070-80. DOI: 10.1038/ki.1992.163. View

4.
Johnsson E, Haraldsson B . An isolated perfused rat kidney preparation designed for assessment of glomerular permeability characteristics. Acta Physiol Scand. 1992; 144(1):65-73. DOI: 10.1111/j.1748-1716.1992.tb09268.x. View

5.
Hildebrand A, Romaris M, Rasmussen L, Heinegard D, Twardzik D, Border W . Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J. 1994; 302 ( Pt 2):527-34. PMC: 1137259. DOI: 10.1042/bj3020527. View